# What is 5-Amino-1MQ? What's been measured · PepVault guides

Source: https://pepvault.app/guides/5-amino-1mq-explained

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [The science](https://pepvault.app/guides#science)

# What is 5-Amino-1MQ? What's been measured

Reviewed November 2026 15 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

5-Amino-1MQ is a small molecule that blocks the NNMT enzyme. What mouse and cell studies measured on fat, muscle and liver, and why no human data exists.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 15
- **Questions:** 10
- **Compounds:** 2

## The short answer

5-Amino-1MQ is a small molecule, not a peptide, that blocks NNMT, an enzyme that runs high in the fat of obese mice. Every result so far comes from mice, rats and cells: in obese mice, daily injections cut body weight and fat without lowering food intake. No human study has been published, and ClinicalTrials.gov lists no registered trial.

Every number checked at its primary source · Nov 20, 2026 · [15 sources](https://pepvault.app/guides/5-amino-1mq-explained#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Animal and cell studies only: no published human study and no registered trial as of November 2026.

## Has 5-Amino-1MQ been tested in people?

No. Every published result for 5-Amino-1MQ comes from mice, rats or cells grown in a dish. A search of ClinicalTrials.gov in November 2026 for "5-amino-1MQ", "5-amino-1-methylquinolinium" and "NNMT inhibitor" returned no registered trial of it[12](https://pepvault.app/guides/5-amino-1mq-explained#source-12), and PubMed lists no human study. Drugs@FDA has no application for it, so it has no FDA-approved form[13](https://pepvault.app/guides/5-amino-1mq-explained#source-13).

That shapes everything below. A mouse result tells you what the molecule did in a mouse, at a dose given by injection, over days to weeks. It is a reason to run a human trial, and it is not yet a result in people.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault logs an oral compound like 5-Amino-1MQ as a daily dose with a reminder, and keeps your weigh-ins and waist on the same timeline, so you can see whether anything moved and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What is 5-Amino-1MQ, and is it a peptide?

It is not a peptide. A peptide is a chain of amino acids; 5-Amino-1MQ is a small ring-shaped molecule, a quinoline ring carrying a methyl group and an amino group, which is what its full name, 5-amino-1-methylquinolinium, spells out[8](https://pepvault.app/guides/5-amino-1mq-explained#source-8). Its charged form weighs about 159 daltons[6](https://pepvault.app/guides/5-amino-1mq-explained#source-6). It sits on peptide sites because people run it beside GLP-1s and other metabolic peptides.

It came out of a drug-discovery program at the University of Texas Medical Branch in Galveston. In 2017 the team screened families of small molecules against the NNMT enzyme and found the methylquinoliniums worked best, blocking it at about 1 micromolar in a test tube[8](https://pepvault.app/guides/5-amino-1mq-explained#source-8). 5-Amino-1MQ was the one they took into animals[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1).

## What does NNMT do in fat cells?

NNMT (nicotinamide N-methyltransferase) is an enzyme that tags vitamin B3, in its nicotinamide form, with a methyl group. Each tag uses up a molecule of SAM, the cell's main methyl donor, and takes the nicotinamide away from the recycling route that rebuilds NAD+, a molecule cells need to turn food into energy[7](https://pepvault.app/guides/5-amino-1mq-explained#source-7).

The interest started with a 2014 Nature paper from Harvard. NNMT levels were raised in the fat and liver of obese and diabetic mice, and when the team switched the gene down in those tissues, the mice burned more energy and were protected from diet-induced obesity[7](https://pepvault.app/guides/5-amino-1mq-explained#source-7). Blocking NNMT raised SAM and NAD+ in fat tissue[7](https://pepvault.app/guides/5-amino-1mq-explained#source-7).

Look at the fork: block NNMT, and nicotinamide and SAM stay in the cell, which is why NAD+ and SAM rose in treated fat cells.

5-Amino-1MQ does the same job with a drug instead of a gene switch. In cultured mouse fat cells it cut the enzyme's product, raised NAD+ about 1.2 to 1.6-fold, raised SAM, and at 30 and 60 micromolar cut new fat production by 50% and 70%[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1). It left related enzymes alone, including the NAD+ recycling enzymes and SIRT1[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1).

## With this guide

### 5-Amino-1MQ

- [5-Amino-1MQ: the full reference](https://pepvault.app/peptides/5-amino-1mq)
- [5-Amino-1MQ dose guide](https://pepvault.app/lab/dosage/5-amino-1mq)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024)
- [5-Amino-1MQ plus low-fat diet gave obese mice a distinct microbiome](https://pepvault.app/research/5-amino-1mq-dimet-wiley-2022)
- [5-Amino-1MQ slowed growth of HeLa cervical cancer cells in the lab](https://pepvault.app/research/5-amino-1mq-akar-2021)
- [All 3 studies](https://pepvault.app/research#5-amino-1mq)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [5-Amino-1MQ vs Semaglutide](https://pepvault.app/peptides/compare/5-amino-1mq-vs-semaglutide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Bioavailability](https://pepvault.app/glossary/bioavailability)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

## What happened to the obese mice?

In the first animal study, obese mice on a high-fat diet got 5-Amino-1MQ by injection under the skin three times a day for 11 days, nine mice per group. Treated mice lost about 5.1% of their body weight while untreated mice gained about 1.4%, and both groups ate about the same amount of food[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1). The main belly fat pad shrank by about 35%, fat cells were over 30% smaller, and total cholesterol was about 30% lower[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1).

The 2021 follow-up added a diet change. Obese mice switched to a lean diet lost about 29% of their fat mass with 5-Amino-1MQ, against about 3% on the diet switch alone, and their ratio of lean mass to body weight rose 6.4%[2](https://pepvault.app/guides/5-amino-1mq-explained#source-2). Their body composition and liver fat ended up at the level of mice kept lean all along[2](https://pepvault.app/guides/5-amino-1mq-explained#source-2).

A 2024 study ran four weeks of once-daily injections in obese mice that stayed on their high-fat diet. The higher dose held back weight and fat gain rather than reversing it, improved how the mice handled sugar and insulin, and reduced fatty liver: one type of fat build-up in the liver fell by 73% against controls[3](https://pepvault.app/guides/5-amino-1mq-explained#source-3). Food intake and lean mass did not change[3](https://pepvault.app/guides/5-amino-1mq-explained#source-3).

| Study | Animals | How it was given | Main result |
| --- | --- | --- | --- |
| Neelakantan 2018[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1) | Obese mice, high-fat diet, 9 per group | Injection three times a day, 11 days | −5.1% body weight vs +1.4% in controls; same food intake |
| Sampson 2021[2](https://pepvault.app/guides/5-amino-1mq-explained#source-2) | Obese mice switched to a lean diet, 8 treated | Daily injection | About 29% fat-mass loss vs about 3% on diet alone |
| Babula 2024[3](https://pepvault.app/guides/5-amino-1mq-explained#source-3) | Obese mice, high-fat diet, 8 per group | Daily injection, about 4 weeks | Less weight and fat gain; less fatty liver |
| Neelakantan 2019[4](https://pepvault.app/guides/5-amino-1mq-explained#source-4) | 24-month-old mice, injured leg muscle | Injection twice a day, 2 to 4 weeks | About 70% more peak muscle force after injury |
| Dimet-Wiley 2024[5](https://pepvault.app/guides/5-amino-1mq-explained#source-5) | Aged female mice, with or without wheel running | Daily injection, 8 weeks | Grip strength +40% alone, +60% with exercise |

Look at both pairs: weight moved apart while food eaten stayed about the same.

These are mouse results, and results in mice often don't carry over to people. Every study in the table gave 5-Amino-1MQ by injection, not by mouth.

## Does it do anything for muscle?

NNMT also rises in muscle with age, and the same group tested whether blocking it helps old muscle repair itself. In 24-month-old mice, old for a mouse, with an injured leg muscle, 5-Amino-1MQ made muscle stem cells more active. The repaired fibers were nearly twice as large in cross-section, and the muscle's peak force was about 70% higher than in untreated mice[4](https://pepvault.app/guides/5-amino-1mq-explained#source-4).

In 2024 aged female mice got eight weeks of daily injections, a weighted running wheel, or both. Grip strength rose about 40% on 5-Amino-1MQ alone, about 20% with exercise alone, and about 60% with both[5](https://pepvault.app/guides/5-amino-1mq-explained#source-5). This, with the 2021 lean-mass result, is where the "keeps muscle on a cut" idea comes from, and both are animal results.

## Does it work when swallowed?

This is the gap that matters most for how people take it. Human pharmacokinetics, how a body absorbs and clears a drug, have not been published. The two animal studies disagree on how much of an oral dose reaches the blood, its bioavailability:

| Species | Share of an oral dose reaching the blood | Half-life after an oral dose |
| --- | --- | --- |
| Rats (Awosemo 2021)[6](https://pepvault.app/guides/5-amino-1mq-explained#source-6) | 38.4% | 6.9 hours |
| Mice (Babula 2024)[3](https://pepvault.app/guides/5-amino-1mq-explained#source-3) | 3.5% | 14.8 hours |

Look at the gap between the bars: the two animal studies disagree ten-fold, and no human figure exists.

The mouse team put its low figure down to poor absorption from the gut and heavy breakdown in the liver, and it gave the drug by injection under the skin, which reached fat, muscle and liver well[3](https://pepvault.app/guides/5-amino-1mq-explained#source-3). Community use is mostly by mouth, the route with the least data behind it. Its half-life, the time for blood levels to halve, also has no human figure.

## Is 5-Amino-1MQ safe?

Nobody knows yet in people. In the mice, the researchers saw no observable adverse effects at the doses tested, and in a short dose-escalation test in two mice a total of 60 mg per kg a day was well tolerated[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1). In the 2021 study, repeated dosing over the seven-week study caused no adverse effects, and blood chemistry showed no sign of organ damage[2](https://pepvault.app/guides/5-amino-1mq-explained#source-2).

One lab screen is worth knowing. Tested at 10 micromolar against a panel of receptors and enzymes, 5-Amino-1MQ hit only one other target, blocking monoamine oxidase A (MAO-A) by 67.4%[3](https://pepvault.app/guides/5-amino-1mq-explained#source-3). MAO-A breaks down brain chemicals such as serotonin, and several medicines, including some antidepressants, act on the same system, so anyone taking one has a good question for a doctor or pharmacist.

NNMT also turns up in cancer research, where blocking it is studied as a way to slow tumors. 5-Amino-1MQ slowed the growth of HeLa cervical cancer cells in a dish while leaving kidney-derived HEK-293 cells largely untouched[10](https://pepvault.app/guides/5-amino-1mq-explained#source-10), and in mice it slowed bladder tumors and helped an immunotherapy drug work[11](https://pepvault.app/guides/5-amino-1mq-explained#source-11). Neither is a weight-loss result, and no person received it.

**Commonly reported:** little to feel from day to day. Only a handful of people on the open forums we read have written about it: a few describe more energy or endurance, or easier fat loss alongside a diet or a GLP-1, others notice nothing, and one person described a flushed face.

## How does it compare with semaglutide?

People often run the two together, so the difference in evidence is worth seeing side by side. Semaglutide is a GLP-1 drug that quiets appetite; 5-Amino-1MQ, in mice, changed fat-cell metabolism without changing how much the animals ate[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1).

| Measure | 5-Amino-1MQ | Semaglutide |
| --- | --- | --- |
| What it is | Small molecule that blocks NNMT | GLP-1 receptor agonist (a peptide) |
| Tested in people | No published study, no registered trial[12](https://pepvault.app/guides/5-amino-1mq-explained#source-12) | Yes: 1,961 adults in STEP 1[14](https://pepvault.app/guides/5-amino-1mq-explained#source-14) |
| Weight result | −5.1% in 11 days, in obese mice[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1) | −14.9% at 68 weeks, against −2.4% on placebo[14](https://pepvault.app/guides/5-amino-1mq-explained#source-14) |
| Appetite | No change in food intake, in mice[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1) | Activates GLP-1 receptors in brain areas that regulate appetite[15](https://pepvault.app/guides/5-amino-1mq-explained#source-15) |
| FDA status | No approved product[13](https://pepvault.app/guides/5-amino-1mq-explained#source-13) | Approved for long-term weight reduction, as Wegovy[15](https://pepvault.app/guides/5-amino-1mq-explained#source-15) |

## Who did the research?

Most of the obesity and muscle work comes from one group, the lab of S. J. Watowich at the University of Texas Medical Branch[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1) [2](https://pepvault.app/guides/5-amino-1mq-explained#source-2) [3](https://pepvault.app/guides/5-amino-1mq-explained#source-3) [4](https://pepvault.app/guides/5-amino-1mq-explained#source-4) [5](https://pepvault.app/guides/5-amino-1mq-explained#source-5). Watowich founded Ridgeline Therapeutics, and H. Neelakantan, an author on every paper in the table, works there. The 2021 diet study, the 2022 gut-bacteria study and both 2024 papers declare that tie[2](https://pepvault.app/guides/5-amino-1mq-explained#source-2) [3](https://pepvault.app/guides/5-amino-1mq-explained#source-3) [5](https://pepvault.app/guides/5-amino-1mq-explained#source-5) [9](https://pepvault.app/guides/5-amino-1mq-explained#source-9). The 2018 and 2019 papers, and the 2021 rat drug-level study that Watowich and Neelakantan co-wrote, declare no conflict[1](https://pepvault.app/guides/5-amino-1mq-explained#source-1) [4](https://pepvault.app/guides/5-amino-1mq-explained#source-4) [6](https://pepvault.app/guides/5-amino-1mq-explained#source-6). A separate study from the same group found that the drug plus a low-fat diet gave obese mice their own gut-bacteria pattern[9](https://pepvault.app/guides/5-amino-1mq-explained#source-9).

Company-linked research is normal at this stage. It also means the fat and muscle findings have not yet been repeated by an independent lab, even in animals; the outside labs that have used it so far studied cancer cells and tumors[10](https://pepvault.app/guides/5-amino-1mq-explained#source-10) [11](https://pepvault.app/guides/5-amino-1mq-explained#source-11).

## If you're tracking it, what's worth logging?

No human dose has been tested, so the range on our 5-Amino-1MQ Dose Guide page is a convention from community use, not a trial result. The mouse findings point to what would show up if anything does: body fat rather than appetite, and strength over weeks.

- Weight and waist on the same day each week, since the mouse effect was on fat rather than on appetite.
- A simple strength marker, such as grip or a working set you repeat.
- Anything new you notice, with the date, including flushing or sleep changes.

<!--promo-->

PepVault logs an oral compound like 5-Amino-1MQ as a daily dose with a reminder, and keeps your weigh-ins and waist on the same timeline, so you can see whether anything moved and when. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-5-amino-1mq-explained-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Neelakantan H et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018. [PubMed 29155147](https://pubmed.ncbi.nlm.nih.gov/29155147/)
2. Sampson CM et al. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice. Sci Rep. 2021. [PubMed 33707534](https://pubmed.ncbi.nlm.nih.gov/33707534/)
3. Babula JJ et al. Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. Diabetes Obes Metab. 2024. [PubMed 39161060](https://pubmed.ncbi.nlm.nih.gov/39161060/)
4. Neelakantan H et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem Pharmacol. 2019. [PubMed 30753815](https://pubmed.ncbi.nlm.nih.gov/30753815/)
5. Dimet-Wiley AL et al. Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Sci Rep. 2024. [PubMed 38969654](https://pubmed.ncbi.nlm.nih.gov/38969654/)
6. Awosemo O et al. Development and validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: application to pharmacokinetic and oral bioavailability studies. J Pharm Biomed Anal. 2021. [PubMed 34304009](https://pubmed.ncbi.nlm.nih.gov/34304009/)
7. Kraus D et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014. [PubMed 24717514](https://pubmed.ncbi.nlm.nih.gov/24717514/)
8. Neelakantan H et al. Structure-activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase. J Med Chem. 2017. [PubMed 28548833](https://pubmed.ncbi.nlm.nih.gov/28548833/)
9. Dimet-Wiley A et al. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. Sci Rep. 2022. [PubMed 35013352](https://pubmed.ncbi.nlm.nih.gov/35013352/)
10. Akar S et al. Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells. J Obstet Gynaecol. 2021. [PubMed 33645410](https://pubmed.ncbi.nlm.nih.gov/33645410/)
11. Yang M et al. NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. J Immunother Cancer. 2024. [PubMed 39067875](https://pubmed.ncbi.nlm.nih.gov/39067875/)
12. ClinicalTrials.gov search for 5-amino-1MQ (no registered studies, searched November 2026). [clinicaltrials.gov](https://clinicaltrials.gov/search?term=5-amino-1MQ)
13. Drugs@FDA via openFDA: no application lists methylquinolinium as an active ingredient (searched November 2026). [api.fda.gov](https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22METHYLQUINOLINIUM%22)
14. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. [PubMed 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
15. WEGOVY (semaglutide) prescribing information, DailyMed, Novo Nordisk, June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)

Two retatrutide samples matched a basic standard; a third held no peptide and 13 bacterial colonies. What the tests and UK seizures show, as of Nov 20, 2026.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [5-Amino-1MQ Studied range: 50–100 mg](https://pepvault.app/peptides/5-amino-1mq)
- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · Stacks

  ### [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

  What to pair with each peptide, and why: glycine and vitamin C for repair, less zinc on GHK-Cu, fasting and sleep for GH peptides, protein on GLP-1s.

  Read the guide
- Guide · GLP-1s

  ### [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)

  What to expect on retatrutide week by week: the trial dose steps, when appetite drops, weight loss at weeks 24, 48 and 80, and how side effects settle.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### 5-Amino-1MQ

- [5-Amino-1MQ: the full reference](https://pepvault.app/peptides/5-amino-1mq)
- [5-Amino-1MQ dose guide](https://pepvault.app/lab/dosage/5-amino-1mq)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024)
- [5-Amino-1MQ plus low-fat diet gave obese mice a distinct microbiome](https://pepvault.app/research/5-amino-1mq-dimet-wiley-2022)
- [5-Amino-1MQ slowed growth of HeLa cervical cancer cells in the lab](https://pepvault.app/research/5-amino-1mq-akar-2021)
- [All 3 studies](https://pepvault.app/research#5-amino-1mq)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [5-Amino-1MQ vs Semaglutide](https://pepvault.app/peptides/compare/5-amino-1mq-vs-semaglutide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Bioavailability](https://pepvault.app/glossary/bioavailability)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
